<DOC>
	<DOC>NCT03029325</DOC>
	<brief_summary>Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.</brief_summary>
	<brief_title>Molecular and Genetic Analysis of Lung Cancer</brief_title>
	<detailed_description>Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>healthy controls: participants without evidence of any cancer cases: pathology proven primary lung cancer younger than 18 years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>